# Sutro Biopharma (STRO) — News

STRO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/stro/news

## Recent headlines

- [Sutro Biopharma appoints Lucas Donigian as senior vice president, business development](https://www.ainvest.com/news/sutro-biopharma-appoints-lucas-donigian-senior-vice-president-business-development-2609) — AInvest Wire, Sep 29, 2026
  Sutro Biopharma has announced the appointment of Lucas Donigian to the role of senior vice president, business development, effective immediately. Donigian brings extensive experience in biotechnology and pharmaceutical business development, having previously held leadership roles at several life…
- [Sutro Biopharma Inc: Stifel initiates coverage with buy rating; price target $48](https://www.ainvest.com/news/sutro-biopharma-stifel-initiates-coverage-buy-rating-price-target-48-2608) — AInvest Wire, Aug 7, 2026
  Stifel has initiated coverage of Sutro Biopharma Inc (NASDAQ: STRO), assigning the biotechnology company a "Buy" rating and a price target of $48 per share [1]. The firm's analysts highlighted Sutro's innovative platform for developing precision oncology therapies and its robust pipeline as key…
- [Sutro Biopharma Inc: Truist Securities assumes coverage with buy rating; target price $50](https://www.ainvest.com/news/sutro-biopharma-truist-securities-assumes-coverage-buy-rating-target-price-50-2606) — AInvest Wire, Jun 11, 2026
- **Important** — Sutro Biopharma jumps 16% in premarket trading. — AInvest Wire, Nov 30, 2023
- Wedbush reiterates outperform on Sutro Biopharma, maintains $12 price target. — AInvest Wire, Oct 23, 2023

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).